Enzon Pharmaceuticals Inc
OTC:ENZN

Watchlist Manager
Enzon Pharmaceuticals Inc Logo
Enzon Pharmaceuticals Inc
OTC:ENZN
Watchlist
Price: 0.042 USD 5% Market Closed
Market Cap: 3.1m USD

Intrinsic Value

The intrinsic value of one ENZN stock under the Base Case scenario is 0.003 USD. Compared to the current market price of 0.042 USD, Enzon Pharmaceuticals Inc is Overvalued by 92%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ENZN Intrinsic Value
0.003 USD
Overvaluation 92%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Enzon Pharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about ENZN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ENZN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Enzon Pharmaceuticals Inc.

Explain Valuation
Compare ENZN to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ENZN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Enzon Pharmaceuticals Inc

Current Assets 44.7m
Cash & Short-Term Investments 44.3m
Other Current Assets 444k
Non-Current Assets 42k
Other Non-Current Assets 42k
Current Liabilities 803k
Accounts Payable 331k
Accrued Liabilities 472k
Efficiency

Free Cash Flow Analysis
Enzon Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Enzon Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-2.2m USD
Operating Income
-2.2m USD
Other Expenses
657k USD
Net Income
-1.6m USD
Fundamental Scores

ENZN Profitability Score
Profitability Due Diligence

Enzon Pharmaceuticals Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Declining ROE
Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative ROE
26/100
Profitability
Score

Enzon Pharmaceuticals Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

ENZN Solvency Score
Solvency Due Diligence

Enzon Pharmaceuticals Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
80/100
Solvency
Score

Enzon Pharmaceuticals Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ENZN Price Targets Summary
Enzon Pharmaceuticals Inc

There are no price targets for ENZN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ENZN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ENZN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ENZN stock?

The intrinsic value of one ENZN stock under the Base Case scenario is 0.003 USD.

Is ENZN stock undervalued or overvalued?

Compared to the current market price of 0.042 USD, Enzon Pharmaceuticals Inc is Overvalued by 92%.

Back to Top